← Open Payments lookup

DANIELLE THREATTS: Open Payments

NPI 1033465778 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,811 in 81 payments from 15 companies in 2025. Trend: 2023 $2,657 · 2024 $2,184 · 2025 $2,811

Food & beverage: $2,811
CompanyPaymentsAmount
ABBVIE INC.17$611
Otsuka America Pharmaceutical, Inc.12$462
Vanda Pharmaceuticals Inc.12$423
Alkermes, Inc.8$253
Axsome Therapeutics, Inc.5$193
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$179
Teva Pharmaceuticals USA, Inc.3$160
Janssen Pharmaceuticals, Inc1$150
E.R. Squibb & Sons, L.L.C.1$122
Corium, LLC9$120

Products named: VRAYLAR, FANAPT, REXULTI, Auvelity, CAPLYTA, ARISTADA, ABILIFY MAINTENA, UZEDY.

Industry payments across LA — which companies pay providers there.